Stenocare Financials
| STENO Stock | DKK 1.98 0.14 6.60% |
Stenocare |
Understanding current and past Stenocare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Stenocare's financial statements are interrelated, with each one affecting the others. For example, an increase in Stenocare's assets may result in an increase in income on the income statement.
Please note, the presentation of Stenocare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Stenocare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Stenocare's management manipulating its earnings.
Stenocare Stock Summary
Stenocare competes with Bavarian Nordic, LUXOR-B, CBrain AS, Fast Ejendom, and PF Atlantic. Stenocare AS cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products in the Danish and European markets. The company was founded in 2017 and is headquartered in Allerd, Denmark. STENOCARE is traded on Copenhagen Stock Exchange in Denmark.| Instrument | Denmark Stock View All |
| Exchange | Copenhagen Exchange |
| ISIN | DK0061078425 |
| Business Address | Frederiksborgvej 54, Allerd, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | stenocare.dk |
| Phone | 45 31 77 00 60 |
| Currency | DKK - Danish Krone |
You should never invest in Stenocare without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Stenocare Stock, because this is throwing your money away. Analyzing the key information contained in Stenocare's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Stenocare Key Financial Ratios
Stenocare's financial ratios allow both analysts and investors to convert raw data from Stenocare's financial statements into concise, actionable information that can be used to evaluate the performance of Stenocare over time and compare it to other companies across industries.| Return On Equity | -0.49 | |||
| Return On Asset | -0.28 | |||
| Beta | 0.11 |
Stenocare Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Stenocare's current stock value. Our valuation model uses many indicators to compare Stenocare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Stenocare competition to find correlations between indicators driving Stenocare's intrinsic value. More Info.Stenocare AS is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Stenocare by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Stenocare's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Stenocare AS Systematic Risk
Stenocare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Stenocare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Stenocare AS correlated with the market. If Beta is less than 0 Stenocare generally moves in the opposite direction as compared to the market. If Stenocare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Stenocare AS is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Stenocare is generally in the same direction as the market. If Beta > 1 Stenocare moves generally in the same direction as, but more than the movement of the benchmark.
Stenocare November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Stenocare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Stenocare AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Stenocare AS based on widely used predictive technical indicators. In general, we focus on analyzing Stenocare Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Stenocare's daily price indicators and compare them against related drivers.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 62.7 | |||
| Value At Risk | (10.26) | |||
| Potential Upside | 8.06 |
Complementary Tools for Stenocare Stock analysis
When running Stenocare's price analysis, check to measure Stenocare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stenocare is operating at the current time. Most of Stenocare's value examination focuses on studying past and present price action to predict the probability of Stenocare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stenocare's price. Additionally, you may evaluate how the addition of Stenocare to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |